Rojas, Giovanni Wladimir 
; Nunes, Altacilio Aparecido
Fonte: Value in Health Regional Issues. Unidade: FMRP
Assuntos: DIABETES MELLITUS, METFORMINA, FARMACOECONOMIA, CUSTO ECONÔMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROJAS, Giovanni Wladimir e NUNES, Altacilio Aparecido. Pharmacoeconomic analysis of sitagliptin/metformin for the treatment of type 2 diabetes mellitus: a cost-effectiveness study. Value in Health Regional Issues, v. 26, p. 33-39, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.vhri.2020.11.008. Acesso em: 16 nov. 2025.APA
Rojas, G. W., & Nunes, A. A. (2021). Pharmacoeconomic analysis of sitagliptin/metformin for the treatment of type 2 diabetes mellitus: a cost-effectiveness study. Value in Health Regional Issues, 26, 33-39. doi:10.1016/j.vhri.2020.11.008NLM
Rojas GW, Nunes AA. Pharmacoeconomic analysis of sitagliptin/metformin for the treatment of type 2 diabetes mellitus: a cost-effectiveness study [Internet]. Value in Health Regional Issues. 2021 ; 26 33-39.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.vhri.2020.11.008Vancouver
Rojas GW, Nunes AA. Pharmacoeconomic analysis of sitagliptin/metformin for the treatment of type 2 diabetes mellitus: a cost-effectiveness study [Internet]. Value in Health Regional Issues. 2021 ; 26 33-39.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.vhri.2020.11.008
